Term
|
Definition
| drugs that reduce inflammation by preventing the inflammatory mediator histamine from binding to its receptor site; same as histamine blockers or histamine antagonists |
|
|
Term
|
Definition
| drug that prevents pr limits tissue and blood vessel responses to injury or invasion |
|
|
Term
|
Definition
| drugs similar to natural cortisol that prevent or limit inflammation by slowing or stopping inflammatory mediator production |
|
|
Term
|
Definition
| enzyme important in converting body chemicals into mediators of inflammation |
|
|
Term
|
Definition
| chemical made by the body that binds to receptor sites and causes inflammatory responses |
|
|
Term
|
Definition
| invasion of the body by microorganisms that disturb the normal environment and cause harm |
|
|
Term
|
Definition
| a syndrome of tissue and blood vessel responses to injury or invasion |
|
|
Term
|
Definition
| group of chemicals made by the body that cause some of the signs and symptoms of inflammation, especially pain |
|
|
Term
|
Definition
| chemical made by the body that binds to its receptors and maintains an inflammatory response |
|
|
Term
|
Definition
| body chemicals such as histamine, leukotriene, prostaglandins, and kinins that cause inflammatory responses |
|
|
Term
| Nonsteroidal Anti-inflammatory Drugs (NSAIDS) |
|
Definition
| anti-inflammatory drugs that are not similar to cortisol but prevent or limit the tissue and blood vessel responses to injury or invasion by slowing the production of one or more inflammatory mediators |
|
|
Term
|
Definition
| family of chemicals made by the body, some of which cause the signs and symptoms of inflammation |
|
|
